CANDISE JORDAN: Open Payments
NPI 1326345042 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,857 in 71 payments from 27 companies in 2025. Trend: 2023 $1,445 · 2024 $1,159 · 2025 $1,857
Food & beverage: $1,666Education: $190
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 18 | $244 |
| ABBVIE INC. | 11 | $228 |
| Incyte Corporation | 2 | $168 |
| AstraZeneca Pharmaceuticals LP | 4 | $159 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $123 |
| Stemline Therapeutics Inc. | 2 | $123 |
| Aveo Pharmaceuticals, Inc. | 2 | $110 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| Gilead Sciences, Inc. | 3 | $68 |
| Dendreon Pharmaceuticals LLC | 2 | $63 |
Products named: ENHERTU, OPDIVO, Orserdu, CREON, FOTIVDA, Trodelvy, PROVENGE, XT CDX.
Industry payments across MO — which companies pay providers there.
